Ind Medxare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-06-2024
- Paid Up Capital ₹ 0.56 M
as on 01-06-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 9.24%
(FY 2017)
- Profit 14.07%
(FY 2017)
- Ebitda -6.76%
(FY 2017)
- Net Worth 45.16%
(FY 2017)
- Total Assets 57.81%
(FY 2017)
About Ind Medxare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.56 M, as per Ministry of Corporate Affairs (MCA) records.
Subrata Kour and Jarnel Singh serve as directors at the Company.
- CIN/LLPIN
U85100AS2012PTC011144
- Company No.
011144
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Jun 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ind Medxare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subrata Kour  | Director | 26-Jun-2012 | Current |
| Jarnel Singh | Director | 26-Jun-2012 | Current |
Financial Performance of Ind Medxare.
Ind Medxare Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 9.24% increase. The company also saw a substantial improvement in profitability, with a 14.07% increase in profit. The company's net worth Soared by an impressive increase of 45.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ind Medxare?
In 2017, Ind Medxare had a promoter holding of 95.54% and a public holding of 4.46%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Welkin Promoters Private LimitedActive 18 years 6 monthsSubrata Kour and Jarnel Singh are mutual person
- Shakshi Barter Private Limited.Active 16 years 4 months
Subrata Kour and Jarnel Singh are mutual person
- Helicon Builders Private LimitedActive 21 years 7 months
Subrata Kour and Jarnel Singh are mutual person
- Jeevan Jyoti Health Care And Research Centre Private LimitedActive 13 years 12 days
Subrata Kour and Jarnel Singh are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ind Medxare?
Unlock and access historical data on people associated with Ind Medxare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ind Medxare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ind Medxare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
